![]() |
||||||||||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||||||
![]() |
||||||||||||||||||||||||||
The Daily Wellness Company, the makers of ArginMax, is committed to supporting scientific research. The Company has taken a methodical and clinical approach toward the development of ArginMax in order to establish the highest level of credibility and consumer trust. Several physician-directed
studies have been conducted on ArginMax, including a recently completed double-blind placebo-controlled study on men with mild to moderate erectile dysfunction -- the first of its kind in the sexual health category. View an abstract of this double-blind placebo-controlled study. In a Other multi-center clinical studies include those evaluating the role of |
||||||||||||||||||||||||||
Clinical Research Clinical research on ArginMax has received
invitation for presentation at the following international medical conferences:
|
||||||||||||||||||||||||||
The results of the ArginMax clinical studies were published in the
Hawaii Medical Journal, The Journal of the Hawaii Medical Association, December 1998 issue |
||||||||||||||||||||||||||
The following summarizes a study conducted on ArginMax: Summary:
We report results from a clinical study examining the effects of ArginMax on male sexual function in a group of men diagnosed with mild to moderate erectile dysfunction. ArginMax (The Daily Wellness Company) is a dietary supplement consisting of a highly standardized combination of ginkgo biloba, Korean ginseng, American ginseng, L-arginine, vitamins A, C, E, B6, and B12, folate, thiamin, riboflavin, niacin, biotin, pantothenic acid, zinc, and selenium.
In our pilot study, twenty-five (25) participants enrolled through a urology clinic were evaluated over a 4-week period while on a twice-a-day regimen of ArginMax. Subjects were enrolled consecutively. The study was open to all
individuals previously diagnosed with mild to moderate erectile dysfunction. Ages ranged from 40-77. Subject progress was measured using a Sexual Function Questionnaire (SFQ) consisting of validated sexual function and quality of
life scoring measures. Following four weeks of a daily regimen of ArginMax, twenty-one (21) subjects that completed the regimen were evaluated.
88.9% of the subjects experienced improvement in ability to maintain an erection during intercourse. 75.0% of the subjects experienced improvement in satisfaction with their overall sex life. No significant reports of side
effects including headaches, nausea, stomach upset, changes in blood pressure, disturbed vision, chest pain, or dizziness were noted. |
||||||||||||||||||||||||||
Several studies report on the effectiveness of various individual ingredients contained in ArginMax. Below is a list of journals and summaries of the studies published by them: |
||||||||||||||||||||||||||
Journal of Urology |
||||||||||||||||||||||||||
Circulation Biochemistry Biophysics Research Communication International Journal of Impotence Research Clinical Experimental Pharmacology and Physiology British Journal of Pharmacology |
||||||||||||||||||||||||||